← Back to Search

Transcranial Magnetic Stimulation

Repetitive TMS for Tourette Syndrome

N/A
Recruiting
Led By Steve W. Wu, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Tourette Syndrome
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after repetitive transcranial magnetic stimulation
Awards & highlights

Study Summary

This trial will help determine if magnetic stimulation of the brain can help people with Tourette Syndrome better control their movements.

Who is the study for?
This trial is for individuals with Tourette Syndrome who often have uncontrollable tics or movements. Participants should not have autism, mood disorders, epilepsy, or any implanted medical devices like pacemakers.Check my eligibility
What is being tested?
The study tests whether Repetitive Transcranial Magnetic Stimulation (TMS), a non-invasive treatment using magnetic fields to stimulate nerve cells in the brain, can help control unwanted actions by targeting a specific area of the brain involved in movement control.See study design
What are the potential side effects?
Repetitive TMS may cause discomfort at the stimulation site on the scalp, headache, lightheadedness, or twitching of facial muscles during treatment. Rarely it could lead to seizures or hearing loss if proper ear protection isn't used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Tourette Syndrome.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after repetitive transcranial magnetic stimulation
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after repetitive transcranial magnetic stimulation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stop Signal Reaction Time (SSRT)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Repetitive TMSExperimental Treatment1 Intervention
Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
814 Previous Clinical Trials
6,531,566 Total Patients Enrolled
3 Trials studying Tourette Syndrome
116 Patients Enrolled for Tourette Syndrome
Steve W. Wu, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

Repetitive TMS (Transcranial Magnetic Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT03628703 — N/A
Tourette Syndrome Research Study Groups: Repetitive TMS
Tourette Syndrome Clinical Trial 2023: Repetitive TMS Highlights & Side Effects. Trial Name: NCT03628703 — N/A
Repetitive TMS (Transcranial Magnetic Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03628703 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experimental research available to participants at the moment?

"Clinicaltrials.gov currently reports that this medical trial is actively enrolling patients, with the earliest listing on April 22nd 2019 and an update as recent as July 20th 2022."

Answered by AI

What is the current participation rate for this trial?

"Affirmative. According to clinicaltrials.gov, this experiment is actively enrolling participants and was first posted on April 22nd 2019. The most recent update occurred in July 20th 2022 and the study requires 15 individuals from a single centre ."

Answered by AI

Is enrollment open to senior citizens aged seventy and above for this medical research?

"The scope of this medical trial includes participants aged 10-17 years old."

Answered by AI

Could I potentially qualify for this research investigation?

"The requirements of this trial stipulate that 15 minors, aged between 10 and 17, who suffer from Tourette syndrome must enroll."

Answered by AI

Who else is applying?

What site did they apply to?
Cincinnati Children's Hospital Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~3 spots leftby Mar 2025